AAAAAA
Results: 26-50/73
Authors:
Shioi, A
Mori, K
Jono, S
Wakikawa, T
Hiura, Y
Koyama, H
Okuno, Y
Nishizawa, Y
Morii, H
Citation: A. Shioi et al., Mechanism of atherosclerotic calcification, Z KARDIOL, 89, 2000, pp. 75-79
Authors:
Muraki, M
Morii, H
Harata, K
Citation: M. Muraki et al., Chemically prepared hevein domains: effect of C-terminal truncation and the mutagenesis of aromatic residues on the affinity for chitin, PROTEIN ENG, 13(6), 2000, pp. 385-389
Authors:
Taniyama, T
Wanibuchi, H
Salim, EI
Yano, Y
Otani, S
Nishizawa, Y
Morii, H
Fukushima, S
Citation: T. Taniyama et al., Chemopreventive effect of 24R,25-dihydroxyvitamin D-3 in N,N'-dimethylhydrazine-induced rat colon carcinogenesis, CARCINOGENE, 21(2), 2000, pp. 173-178
Authors:
Inaba, M
Morii, H
Katsumata, T
Goto, H
Ishimura, E
Kawagishi, T
Kamao, M
Okano, T
Nishizawa, Y
Citation: M. Inaba et al., Hyperparathyroidism is augmented by ovariectomy in Nagase analbuminemic rats, J NUTR, 130(6), 2000, pp. 1543-1547
Authors:
Sakaizumi, T
Imajo, H
Yamasaki, R
Usami, T
Kawaji, S
Abe, S
Haraga, T
Morii, H
Kuze, N
Ohashi, O
Citation: T. Sakaizumi et al., Generation, microwave spectrum, barrier to internal rotation of methyl group, and ab initio MO calculation of syn-2-nitrosopropene, syn-CH2==C(CH3)-N==O, J MOL SPECT, 204(1), 2000, pp. 26-35
Authors:
Tahara, H
Imanishi, Y
Yamada, T
Tsujimoto, Y
Tabata, T
Inoue, T
Inaba, M
Morii, H
Nishizawa, Y
Citation: H. Tahara et al., Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia, J CLIN END, 85(11), 2000, pp. 4113-4117
Authors:
Kumeda, Y
Inaba, N
Tahara, H
Kurioka, Y
Ishikawa, T
Morii, H
Nishizawa, Y
Citation: Y. Kumeda et al., Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism, J CLIN END, 85(11), 2000, pp. 4157-4161
Authors:
Morii, H
Nishihara, M
Koga, Y
Citation: H. Morii et al., CTP : 2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase inthe methanogenic archaeon Methanothermobacter thermoautotrophicus, J BIOL CHEM, 275(47), 2000, pp. 36568-36574
Authors:
Shoji, T
Nishizawa, Y
Fukumoto, M
Shimamura, K
Kimura, J
Kanda, H
Emoto, M
Kawagishi, T
Morii, H
Citation: T. Shoji et al., Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects, ATHEROSCLER, 148(1), 2000, pp. 171-177
Authors:
Khonik, VA
Kitagawa, K
Morii, H
Citation: Va. Khonik et al., On the determination of the crystallization activation energy of metallic glasses, J APPL PHYS, 87(12), 2000, pp. 8440-8443
Authors:
Jono, S
McKee, MD
Murry, CE
Shioi, A
Nishizawa, Y
Mori, K
Morii, H
Giachelli, CM
Citation: S. Jono et al., Phosphate regulation of vascular smooth muscle cell calcification, CIRCUL RES, 87(7), 2000, pp. E10-E17
Authors:
Nakazawa, T
Nakano, I
Furuyama, T
Morii, H
Tamai, M
Mori, N
Citation: T. Nakazawa et al., The SCG10-related gene family in the developing rat retina: Persistent expression of SCLIP and stathmin in mature ganglion cell layer, BRAIN RES, 861(2), 2000, pp. 399-407
Authors:
Iwamoto, M
Murata, T
Morii, H
Watanabe, Y
Nakaoka, Y
Citation: M. Iwamoto et al., Activation of prostacyclin synthesis by mechanical stimulation in the ciliated protozoan Tetrahymena thermophila, BIOC BIOP R, 279(2), 2000, pp. 635-638
Authors:
Murata, T
Morii, H
Watanabe, Y
Matsumura, K
Watanabe, Y
Nakaoka, Y
Citation: T. Murata et al., Prostaglandin I-2, a possible thermo-sensory mediator in Paramecium, BIOC BIOP R, 273(2), 2000, pp. 516-520
Authors:
Yamakawa, K
Hosoi, M
Koyama, H
Tanaka, S
Fukumoto, S
Morii, H
Nishizawa, Y
Citation: K. Yamakawa et al., Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells, BIOC BIOP R, 271(3), 2000, pp. 571-574
Authors:
Kanamasa, K
Nakabayashi, T
Hayashi, T
Inoue, Y
Ikeda, A
Morii, H
Naito, N
Ishikawa, K
Citation: K. Kanamasa et al., Percutaneous transluminal coronary angioplasty performed 24-48 hours afterthe onset of acute myocardial infarction improves chronic-phase left ventricular regional wall motion, ANGIOLOGY, 51(4), 2000, pp. 281-288
Authors:
Hayashi, K
Kamigaki, M
Morii, H
Okuyama, K
Citation: K. Hayashi et al., Novel method for coating magnetic iron oxide particles with carbon black, J AM CERAM, 83(12), 2000, pp. 2901-2906
Authors:
Morii, H
Yagi, H
Akutsu, H
Nomura, N
Sako, Y
Koga, Y
Citation: H. Morii et al., A novel phosphoglycolipid archaetidyl(glucosyl)inositol with two sesterterpanyl chains from the aerobic hyperthermophilic archaeon Aeropyrum pernix K1, BBA-MOL C B, 1436(3), 1999, pp. 426-436
Authors:
Mori, K
Shioi, A
Jono, S
Nishizawa, Y
Morii, H
Citation: K. Mori et al., Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells, ART THROM V, 19(9), 1999, pp. 2112-2118
Authors:
Kawagishi, T
Matsuyoshi, M
Emoto, M
Taniwaki, H
Kanda, H
Okuno, Y
Inaba, M
Ishimura, E
Nishizawa, Y
Morii, H
Citation: T. Kawagishi et al., Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes, ART THROM V, 19(10), 1999, pp. 2509-2516
Authors:
Imanishi, Y
Inaba, M
Seki, H
Koyama, H
Nishizawa, Y
Morii, H
Otani, S
Citation: Y. Imanishi et al., Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D-3 on bovine parathyroid cells, J STEROID B, 70(4-6), 1999, pp. 243-248
Authors:
Inaba, M
Nishizawa, Y
Mita, K
Kumeda, Y
Emoto, M
Kawagishi, T
Ishimura, E
Nakatsuka, K
Shioi, A
Morii, H
Citation: M. Inaba et al., Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D-3 in patients with type 2 diabetes, OSTEOPOR IN, 9(6), 1999, pp. 525-531
Authors:
Fujita, T
Inoue, T
Morii, H
Morita, R
Norimatsu, H
Orimo, H
Takahashi, HE
Yamamoto, K
Fukunaga, M
Citation: T. Fujita et al., Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: A randomized double-masked prospective study using three dose levels, OSTEOPOR IN, 9(4), 1999, pp. 296-306
Authors:
Genant, HK
Cooper, C
Poor, G
Reid, I
Ehrlich, G
Kanis, J
Nordin, BEC
Barrett-Connor, E
Black, D
Bonjour, JP
Dawson-Hughes, B
Delmas, PD
Dequeker, J
Eis, SR
Gennari, C
Johnell, O
Johnston, CC
Lau, EMC
Liberman, UA
Lindsay, R
Martin, TJ
Masri, B
Mautalen, CA
Meunier, PJ
Miller, PD
Mithal, A
Morii, H
Papapoulos, S
Woolf, A
Yu, W
Khaltaev, N
Citation: Hk. Genant et al., Interim report and recommendations of the World Health Organization task-force for osteoporosis, OSTEOPOR IN, 10(4), 1999, pp. 259-264
Authors:
Shiraki, M
Kushid, K
Fukunaga, M
Kishimoto, H
Taga, M
Nakamura, T
Kaneda, K
Minaguchi, H
Inoue, T
Morii, H
Tomita, A
Yamamoto, K
Nagata, Y
Nakashima, M
Orimo, H
Citation: M. Shiraki et al., A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis, OSTEOPOR IN, 10(3), 1999, pp. 183-192